This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Steinbach, W. J. Articles by Perfect, J. R. Search for Related Content PubMed PubMed Citation Articles by Steinbach, W. J. Articles by Perfect, J. R.

CASE REPORT

Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin, as Well as Locally Applied Polyhexamethylene Biguanide

Division of Pediatric Infectious Diseases, Department of Pediatrics,¹ Division of Infectious Diseases and International Health, Department of Medicine,³ Mycology Research Unit, Duke University, Durham, North Carolina 27710²

Received 21 January 2003/ Returned for modification 9 April 2003/ Accepted 16 May 2003

Scedosporium species are increasingly isolated from immunocompromised and immunocompetent patients. Unfortunately, Scedosporium infections are generally resistant to amphotericin B, and Scedosporium prolificans strains are particularly resistant to the antifungal agents now in use. We report here on an immunocompetent child with S. prolificans-associated osteomyelitis successfully treated with debridement, local irrigation with polyhexamethylene biguanide, and the systemic administration of voriconazole and caspofungin despite poor in vitro activity of voriconazole alone against the isolate. We also review the treatments and outcomes of 28 reported cases of osteomyelitis or septic arthritis caused by Scedosporium species in immunocompetent patients.

This article has been cited by other articles:

• Lindsley, M. D., Guarro, J., Khairy, R. N., Williams, J., Iqbal, N., Pancholi, P. (2008). Pseudallescheria fusoidea, a New Cause of Osteomyelitis. J. Clin. Microbiol. 46: 2141-2143 [Abstract] [Full Text]  
• Troke, P., Aguirrebengoa, K., Arteaga, C., Ellis, D., Heath, C. H., Lutsar, I., Rovira, M., Nguyen, Q., Slavin, M., Chen, S. C. A., on behalf of the Global Scedosporium Study Group, (2008). Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients. Antimicrob. Agents Chemother. 52: 1743-1750 [Abstract] [Full Text]  
• Cuenca-Estrella, M., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Gomez-Lopez, A., Buitrago, M. J., Mellado, E., Rodriguez-Tudela, J. L. (2008). In Vitro Activities of 35 Double Combinations of Antifungal Agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob. Agents Chemother. 52: 1136-1139 [Abstract] [Full Text]  
• Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., Rinaldi, M. G., Shea, Y. R., Zaoutis, T., Kottilil, S., Walsh, T. J. (2008). Infections Caused by Scedosporium spp.. Clin. Microbiol. Rev. 21: 157-197 [Abstract] [Full Text]  
• Wormley, F. L. Jr., Heinrich, G., Miller, J. L., Perfect, J. R., Cox, G. M. (2005). Identification and Characterization of an SKN7 Homologue in Cryptococcus neoformans. Infect. Immun. 73: 5022-5030 [Abstract] [Full Text]  
• Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., Ghannoum, M. A. (2005). Combination Treatment of Invasive Fungal Infections. Clin. Microbiol. Rev. 18: 163-194 [Abstract] [Full Text]  
• Cuenca-Estrella, M. (2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother 54: 854-869 [Abstract] [Full Text]